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https://doi.org/10.1016/j.celrep.2021.109032SUMMARYX chromosome inactivation (XCI) is a dosage compensation mechanism in female mammals whereby tran-
scription from one X chromosome is repressed. Analysis of human induced pluripotent stem cells (iPSCs)
derived from female donors identified that low levels of XISTRNAcorrelated strongly with erosion of XCI. Pro-
teomic analysis, RNA sequencing (RNA-seq), and polysome profiling showed that XCI erosion resulted in
amplified RNA and protein expression from X-linked genes, providing a proteomic characterization of
skewed dosage compensation. Increased protein expression was also detected from autosomal genes
without an mRNA increase, thus altering the protein-RNA correlation between the X chromosome and auto-
somes. XCI-eroded lines display an 13% increase in total cell protein content, with increased ribosomal
proteins, ribosome biogenesis and translation factors, and polysome levels. We conclude that XCI erosion
in iPSCs causes a remodeling of the proteome, affecting the expression of a much wider range of proteins
and disease-linked loci than previously realized.INTRODUCTION
In humans and other mammalian species, female cells have two
copiesof theXchromosome,whereasmaleshaveasingleXchro-
mosome and amuch smaller Y chromosome that is not present in
females. In females, one of the two X chromosomes undergoes
silencing, causing repression of transcription and thereby inacti-
vating expression of alleles located on this second copy of the
X. This process is termed X chromosome inactivation (XCI).
The XCI process in female cells is considered a critical dosage
compensation mechanism that evolved in mammals as a way to
equalize X-linked gene expression between males and females
(Graves, 2016; Livernois et al., 2012). XCI is vital for embryonic
development, and failure to induce XCI has been shown to cause
embryonic lethality (Borensztein et al., 2017; Takagi and Abe,
1990). Furthermore, skewed XCI has also been shown to have
major clinical consequences, with the emergence of numerous
sex-specific genetic disorders, such as Rett’s syndrome (Lyst
and Bird, 2015).
The initiation of XCI is controlled by a specific locus, termed the
X-inactivation center (Xic) (Augui et al., 2011). The mechanism of
XCI involves a profound structural reorganization of the inacti-This is an open access article undvated copy of the X chromosome, which becomes heterochro-
matic and visibly compacted (Augui et al., 2011; Giorgetti et al.,
2016). Within the Xic, a long, non-coding RNA, called ‘‘XIST,’’
has been shown to be an important component of the XCI pro-
cess (Marahrens et al., 1997; Penny et al., 1996). Accumulation
of XIST RNA across the inactive copy of the X chromosome trig-
gers the changes that produce the transcriptionally inactive state
(Dossin et al., 2020; Galupa and Heard, 2018).
Over a decade ago, breakthrough studies reported that termi-
nally differentiated somatic cells could be reprogrammed back
into a pluripotent state by the exogenous expression of a small
set of transcription factors (Takahashi et al., 2007; Takahashi
and Yamanaka, 2006; Yu et al., 2007). The resulting human
induced pluripotent stem cells (iPSCs) were shown to share
the hallmarks of their embryonic counterparts, including the in-
duction of XCI (Wutz, 2012). However, for these cells, as well
as for human embryonic stem cells (hESCs), XCI has been shown
to be unstable in culture. Thus, some human primed iPSCs
exhibit erosion of XCI, for which the X chromosome loses
H3K27me3 marks, as well as XIST RNA expression (Anguera
et al., 2012; Dandulakis et al., 2016; Mekhoubad et al., 2012).
Although the role of XIST in relation to erosion of XCI remainsCell Reports 35, 109032, April 27, 2021 ª 2021 The Authors. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
(legend on next page)






OPEN ACCESSunclear, it has been reported that the loss of XIST expression is
characteristic of class III hESCs that display eroded XCI (Geens
and Chuva De Sousa Lopes, 2017).
In this study, we explore the global consequences for human
gene expression when XCI is eroded by using a collection of
iPSCs derived from healthy female donors that were all reprog-
rammed from primary skin fibroblasts (Kilpinen et al., 2017). Spe-
cifically, we have analyzed the impact of XCI erosion by using 74
independent HipSci (https://www.hipsci.org) iPSC lines derived
from female donors and also compared them to 46 lines derived
frommale donors by using both RNA sequencing (RNA-seq) and
proteomic data (Mirauta et al., 2020). The data show that for our
collection of iPSCs, a decrease in the expression of the lncRNA
XIST was correlated with significantly higher biallelic expression,
reflecting increased erosion of XCI.
We also report a global analysis comparing in parallel RNA and
protein expression levels for lines that were stratified based upon
having either high or low expression levels of XIST RNA. We pro-
vide an in-depth analysis of how erosion of XCI in human cells af-
fects gene expression at the protein level. The data show that
erosion of XCI increases both transcription and protein produc-
tion from genes on the inactive X chromosome, and compari-
sons to the male lines show this erosion significantly affects
dosage compensation at the protein level. Remarkably, we
also uncover a widespread increase in the abundance of many
proteins encoded by genes on the autosomes, independent of
a parallel increase in transcription. Female cell lines with low
levels of XIST RNA show amedian increase of13% in total pro-
tein content, along with higher levels of polysomes and compo-
nents of the translational machinery. These data indicate that
erosion of XCI can affect the expression of a much wider range
of proteins and disease-linked gene loci than previously realized
based on RNA analysis alone.
All of the raw and processed mass spectrometry (MS) files are
available within PRIDE (Perez-Riverol et al., 2019; Vizcaı́no et al.,
2016) (PRIDE:PXD010557), and the RNA-seq data are available
within ENA (Amid et al., 2020) (ENA:PRJEB7388).
RESULTS
RNA-seq and proteomic datasets
All of the iPSC lines used for this study were generated by the
HipSci project (https://www.hipsci.org). They were reprog-
rammed from human primary skin fibroblasts and subjected to
rigorous quality-control procedures, which included array-based
genotyping and gene expression profiling, as well as an evalua-
tion of their pluripotency and differentiation properties (Kilpinen
et al., 2017). This study analyzes gene expression data (Brenes
et al., 2019; Mirauta et al., 2020) generated from 74 independentFigure 1. Comprehensive coverage
For all boxplots, the top and bottom hinges represent the 1st and 3rd quartiles. Th
interquartile range (IQR) from the hinge; the bottom whisker extends from the hin
(A) The HipSci proteomics workflow from reprogramming to identification and qu
(B) Boxplot showing the number of proteins identified per line across the 56 filte
(C) Boxplot showing the sequence coverage for all proteins detected within the
(D) Pie chart showing the overlap between quantified gene products in the prote
(E) Scatterplot comparing the median log2 transcripts per million (TPM) versus thiPSC lines derived from healthy female donors and 46 lines
derived from healthy male donors. The lines were grown using
identical culture conditions, and aliquots were divided for parallel
RNA-seq and proteomic analyses. The MS-based proteomic
data were acquired using a tandem mass tag (TMT) workflow
(see STAR Methods; Figure 1A).
The proteomic data for this study were processed using Max-
Quant (Cox and Mann, 2008; Tyanova et al., 2016) and searched
against the manually curated SwissProt database (The UniProt
Consortium, 2017) with a 1% false discovery rate (FDR)
threshold at the peptide spectrummatch (PSM) and protein level
(for more details see STAR Methods). Overall, it detected the
expression of >9,500 protein groups (i.e., proteins/protein iso-
forms without discriminating peptides; hereafter termed pro-
teins; Table S1), with amedian of 8,479 proteins identified across
all lines (Figure 1B), and a median protein sequence coverage of
42% across all proteins (Figure 1C). All downstream analyses
were performed on a subset of 8,908 proteins, which were
each identified with at least 3 ‘‘Razor + unique peptides’’ (RUP;
ie., the number of unique peptides, plus the number of shared
peptides used for the quantification of a protein; see STAR
Methods). To compare protein expression levels between the
respective iPSC lines, protein copy numbers were estimated us-
ing the ‘‘proteomic ruler’’ (Wisniewski et al., 2014) approach and
using the batch correction method previously described (Brenes
et al., 2019; Plubell et al., 2017). This is well suited for the analysis
of HipSci lines, which have been shown to have near-identical
DNA content (Kilpinen et al., 2017).
From the RNA-seq data, after filtering, a total of 12,798 tran-
scripts were quantified, (see STAR Methods; Table S1), with
matching protein level data for 65% of them (Figure 1D). To
explore the relationship between RNA and protein abundance
levels in this set of iPSC lines, we calculated the Pearson corre-
lation of mRNA abundance versus protein abundance (Fig-
ure 1E). This resulted in a Pearson correlation coefficient of
0.62, which is similar to that reported by multiple previous
studies comparing mRNA and protein expression levels, both
in different human cell types and for other mammalian species
(Edfors et al., 2016; Lundberg et al., 2010; Ly et al., 2014).
Erosion of XCI
As it hadbeenpreviously reported that therewasacorrelationbe-
tween the loss of XIST RNA coating the inactive X chromosome
and erosion of XCI, we first evaluated the relationship between
the levels of XIST RNA expression and the erosion of XCI within
the HipSci iPSC lines, as measured by an allele-specific expres-
sion (ASE) analysis on X-linked genes (Figure 2A). This showed a
clear correlation between iPSC lines with low XIST expression
and increased levels of biallelic expression for X-linked genes.e top whisker extends from the hinge to the largest value no further than 1.5 3
ge to the smallest value at most 1.5 3 IQR of the hinge.
antification.
red (see STAR Methods) female iPSC lines.
dataset.
omics and RNA-seq datasets.
e median log10 copy number for all gene products.
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OPEN ACCESSInterestingly, a parallel analysis focused on XACT RNA, another
long non-coding RNA implicated in the mechanism of XCI in hu-
mans (Vallot et al., 2017), showed little to no correlation with
altered biallelic expression in these iPSC lines (Figure S1).
Next, the 74 iPSC lines were stratified into low, medium, and
high XIST RNA populations, based on the RNA-seq expression
data (Figure 2B; Table S2). This identified two main populations,
with 47.3% showing the expected high levels of XIST RNA and a
surprisingly elevated proportion, 40.5%, of the iPSC lines having
very low levels of XIST RNA expression (Figure 2C). Aminor pop-
ulation (12.2%) that showed an intermediate level of XIST
expression was also identified. However, as this population rep-
resented a low number of iPSC lines it was not used for the main
downstream analysis. The rest of the study focused on
comparing gene expression specifically between the popula-
tions stratified by high and low levels of XIST RNA expression.
We next set out to examine the relationship between XIST
expression levels and allelic expression within X-linked gene
products (Figure 2D). This analysis showed that iPSC lines with
high levels of XIST expression had a significantly lower (p =
2.2e16) fraction of genes, with reads derived from the lowest ex-
pressed allele (hereafter termed secondary allele; see STAR
Methods), compared to the low XIST population. Gene products
within iPSC lines displaying high levels of XIST had a median of
99.5% of reads originating from the highest expressed allele
(hereafter termed primary allele; see STAR Methods), with only
0.5% from the secondary allele. iPSC lines with low levels of
XIST showed an increase in the proportion of reads derived
from the secondary allele, with a median of 22.6%, and with
77.4% of reads derived from the primary allele. We therefore
conclude that XIST expression levels provide a suitable marker
for detecting erosion of XCI within the iPSC lines analyzed.
We next mapped all the X-linked genes to their respective
bands within the X chromosome and studied allele expression
for genes across all bands, for both the high and low XIST
populations (Figure 2E). These data again emphasize that the
population with high XIST expression has much lower biallelic
expression than the low XIST population. However, it was
apparent that the level of biallelic expression is not uniform
across the X chromosome. Even within the high XIST population,
certain bands, such as Xp22, Xq23, and Xq26, are more prone toFigure 2. XIST and XCI
For all boxplots, the bottom and top hinges represent the 1st and 3rd quartiles. Th
IQR from the hinge; the bottom whisker extends from the hinge to the smallest v
(A) Scatterplot showing the ratio of reads derived from the secondary allele (lowes
all X-linked transcripts versus the log2 XIST TPM for all healthy female lines. The si
(B) Boxplot showing log2 TPM for the long non-coding RNA XIST across all 3 po
(C) Pie chart showing the percentage of healthy female lines within each XIST-st
(D) Stacked density plot for all X-linked gene products across all lines showing the
both the high and low XIST populations.
(E) X chromosomemap showing the ratio of reads derived from the secondary alle
and low XIST populations. The size of the rectangles represents the number of g
(F) X chromosome map showing the log2 fold change (low/high XIST) across chro
rectangles represents the number of gene products per band.
(G) Boxplot showing the Pearson correlation coefficient comparing log2 fold chan
Autosomes are colored in gray; the X chromosome is colored in red.
(H) Bar plot showing the median log2 fold change (low/high XIST) for all gene pro
The error bars represent the SEM.displaying increased expression from the secondary allele (Fig-
ure 2E). These same bands also displayed higher biallelic
expression within the low XIST population.
We expanded the chromosomal band analysis by calculating
the median log2 fold change between the high and low XIST pop-
ulations, for all gene products and across all bands, at both the
RNA-seq and proteomics levels (Figure 2F). As seen for the allelic
expression, the fold change across chromosomal bands was not
uniform. Interestingly, some of the hotspots highlighted by the
allelic analysis (e.g., bands Xp22, Xq23, and Xq26) were also
among the sites showing highest levels of change inRNA and pro-
tein expression. This is consistent with previous observations
showing that there are specific loci that can preferentially escape
XCI (BalatonandBrown,2016;Tukiainenet al., 2017).Wenote that
the independent transcriptomic and proteomic datasets both dis-
played very similar patterns of gene expression variation in
response to XIST levels across the X chromosome. This concor-
dance in RNA- and protein-level data is consistent with a predom-
inantly transcription-driven regulationofX-linkedgeneexpression.
We also wanted to understand how the changes in gene
expression between the high and low XIST populations behaved
for genes across all other chromosomes. Hence, we used all
gene products that were detected both in both the RNA-seq
and proteomics datasets, aggregated them at the chromosome
level, and compared their respective RNA and protein fold
changes. This chromosome-specific view showed that the high-
est fold change concordance is observed within X-linked genes,
with a Pearson correlation of 0.56 (Figure 2G). However, this
same level of concordance was not observed across all other
chromosomes, as each of the autosomes had a much lower cor-
relation coefficient than was seen for the X chromosome, with
the second highest being chromosome 10 with a correlation co-
efficient of 0.36 and the median being 0.27. The data thus indi-
cate a difference between X-linked genes and genes on all of
the autosomes.
To quantify these differences, we compared the median fold
change for RNAs and proteins across all chromosomes (Fig-
ure 2H). Unsurprisingly, the highest median increase observed
within the low XIST, compared to the high XIST population, at
both the RNA and protein levels, occurs for genes on the X chro-
mosome. However, the proteomics data, unlike the RNA-seqe top whisker extends from the hinge to the largest value no further than 1.5 3
alue at most 1.5 3 IQR of the hinge.
t expressed allele) compared to the primary allele (highest expressed allele) for
ze of the circle is determined by the number of transcripts used for the analysis.
pulations, namely, low, medium, and high XIST.
ratified population.
ratio of readsmapped to the secondary allele compared to the primary allele for
le compared to the primary allele across chromosomal bands for both the high
ene products per band.
mosomal bands for both the RNA-seq and proteomic datasets. The size of the
ge (low/high XIST) at the RNa-seq and proteomics level for all chromosomes.
ducts aggregated at the chromosome level for both RNA-seq and proteomics.
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OPEN ACCESSdata, also displayed increased median fold changes across all
other chromosomes as well.
In summary, the RNA expression data show that iPSC lines
with high levels of XIST RNA display significantly lower biallelic
expression than the iPSC lines with low levels of XIST, with
99.5% of the reads derived from the primary allele and only
0.5% from the secondary allele. The lines with low expression
of XIST showed a higher proportion of reads derived from the
secondary allele (22.6%), consistent with erosion of XCI. The
data also show that erosion of XCI in iPSCs results in both
increased transcription and protein expression for X-linked
genes. However, the same was not observed for genes on the
autosomes, for which the increased median fold change seen
across all chromosomes was detected only at the protein level.
Impact of XCI erosion on the autosomes and dosage
compensation
Next, we focused on a differential expression analysis,
comparing the high versus low XIST-stratified populations at
both the RNA and protein levels. This analysis showed that
55% of X-linked genes in the low XIST population exhibited
significantly increased expression of both RNA and protein, as
compared to the high XIST population (Figures 3A and 3B; Table
S3). However, when comparing gene expression from auto-
somes, once again, we detected differences between the RNA
and protein datasets. Thus, 9% of autosomal transcripts (1,087
out of 12,042) were significantly increased in expression and
11.2% (1,344 out of 12,042; Table S4) were significantly
decreased in expression in the low XIST compared to the high
XIST population. In contrast, the proteomics data showed that
27.8% of the quantified autosome-encoded proteins (2,383 out
of 8,593; Table S4) were significantly increased in expression
in the low XIST population, whereas only 1.2% of autosome-en-
coded proteins (107 out of 8,593) were significantly decreased in
expression (Figure 3B). These results show that there is a clear
effect within the proteomics data that is not recapitulated by
the RNA-seq data.
Based on the increased fold change across all chromosomes
and significantly increased expression of over 2,300 autosomal
proteins, we suspected that the low XIST population of iPSC
lines may have a higher average protein content per cell, as
compared to the high XIST population. To test this hypothesis,
we used the MS data to estimate the total protein content and
compare both XIST-stratified populations to each other. Further-
more, this dataset also provided an opportunity to study the
impact of human dosage compensation at the protein level
and thus to determine how the global proteome may respond
to erosion of XCI. Hence, we also compared both XIST-stratified
populations to 46 iPSC lines derived from healthy male donors
(see STAR Methods).
No significant differences in total protein content were de-
tected between the high XIST female lines and the male lines
(Figure 3C). However, the low XIST population had a significant
increase (p = 0.042) of 7.3% in total protein content compared
to the male lines and an even more pronounced increase
(p = 0.006) of 13.2% compared to the high XIST lines (Figure 3C).
To check if these changes in protein content were related to po-
tential cell cycle differences between the respective stratified6 Cell Reports 35, 109032, April 27, 2021populations, we analyzed the expression of a panel of genes pre-
viously characterized as being cell cycle regulated (Ly et al.,
2014). Gene expression at both the RNA and protein levels
showed no significant differences for these known cell-cycle-
regulated genes between the high and low XIST populations
(Figure S2). Hence, we conclude that the observed differences
in protein content linked with erosion of XCI are likely not the
result of altered kinetics of cell cycle progression.
We drilled down on these comparisons further and focused on
the total copy numbers for all X-linked proteins across both
XIST-stratified female populations and the male lines. Once
again, this comparison revealed no significant differences be-
tween the high XIST female population and themales (Figure 3D).
In contrast, the low XIST population saw a dramatic increase in
protein copy numbers of 27% (p = 0.0032) compared to the
males (Figure 3D). When we repeated this analysis for autosomal
proteins (Figure 3E), the low XIST female population displayed
6.5% higher (p = 0.052) protein copy numbers than the males
and 11.8% higher (p = 0.00099) protein copy numbers than the
high XIST female population. Hence, these data suggested there
was little or no significant difference in total protein levels be-
tween the high XIST female population and iPSC lines from
male donors, whereas the low XIST female population was
significantly different from both. The medium XIST population
appeared to be more closely aligned to the high XIST than to
the low XIST population (Figure S3)
To obtain a more granular view, we compared the changes in
expression for each protein within both the high and low XIST fe-
male populations, in comparison to themale population, for each
of their respective chromosomes (Figure 3F). When comparing
the male to high XIST female lines, we found no significant fold
change difference between the X chromosome and any other
chromosome. This finding demonstrates that XCI is effective at
ensuring similar expression levels of X linked proteins between
males and females with robust XCI. However, the situation is
different when comparing male-derived lines with low XIST fe-
male lines, for which themedian fold change of proteins encoded
by genes on the X chromosome is significantly higher than for
genes on all other chromosomes.
Proteome-specific response to XCI
We next investigated in more detail how the proteome was
altered in the low XIST population and examined which types
of proteins and which protein functions showed changes. We
focused on proteins that showed significantly increased expres-
sion (q < 0.05) in the Low XIST population compared to the high
XIST population, but without a corresponding significant in-
crease in the RNA-seq data. We discovered that this group of
proteins were robust identifications, as they were enriched in
high abundance proteins (abundance greater than the 75th
percentile; see STAR Methods), with high numbers of RUPs de-
tected (RUP greater than the 75th percentile; Figures 4A and 4B).
A follow-up analysis, focused on biological processes, was
carried out by a Gene Ontology (GO) overrepresentation test, us-
ing Panther (Mi et al., 2017). This analysis showed that these pro-
teins were enriched specifically for the GO terms ‘‘ribonucleo-
protein complex biogenesis’’ and ‘‘mRNA metabolic process.’’
We note that these enriched GO terms are associated with
Figure 3. Multi-omic overview
For all boxplots, the bottom and top hinges represent the 1st and 3rd quartiles. The top whisker extends from the hinge to the largest value no further than 1.5 3
IQR from the hinge; the bottom whisker extends from the hinge to the smallest value at most 1.5 3 IQR of the hinge.
(A) Volcano plot showing the log2 fold change (low/high XIST) on the x axis, with the log10 p value on the y axis for the RNA-seq dataset. X chromosome
transcripts are highlighted in red; autosome transcripts are colored gray. All transcripts above the orange line have a p value lower than 0.05.
(B) Volcano plot showing the log2 fold change (low/high XIST) on the x axis, with thelog10 p value on the y axis for the proteomic dataset. X chromosome proteins
are highlighted in red; autosomal proteins are colored gray. All proteins above the orange line have a p value lower than 0.05.
(C) Boxplot showing the estimated protein content (see STAR Methods) for the high XIST, low XIST, and male populations.
(D) Boxplot showing the sum of protein copy numbers across the X chromosome for the high XIST, low XIST, and male lines.
(E) Boxplot showing the sum of protein copy numbers across all autosomes for the high XIST, low XIST, and male lines.
(F) Boxplot showing the median protein log2 fold change (high XIST/Males and low XIST/Males) across all chromosomes.
Article
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OPEN ACCESSmany proteins involved in post-transcriptional mechanisms that
could increase total protein expression from a constant amount
of mRNA. This includes genes related to processes including
ribosome subunit biogenesis, ribosome function, and the control
of protein translation. Consistent with this result, when
comparing changes in expression at the respective RNA and
protein levels between the XIST stratified populations, we foundthat Pearson correlation coefficients were particularly low for the
ribosomal (0.09) and ribosome subunit biogenesis (0.15) proteins
(Figure 4C). This finding indicates a potentially important role for
post-transcriptional mechanisms in regulating protein expres-
sion from these genes.
Overall, >36% of all proteins involved in ribosome subunit
biogenesis, as described in KEGG (Kanehisa and Goto, 2000),Cell Reports 35, 109032, April 27, 2021 7
(legend on next page)






OPEN ACCESSshowed significantly increased (q < 0.05) expression within the
low XIST population, and of these proteins, >70% of those
involved in the cytoplasmic stages of ribosome subunit biogen-
esis showed increased protein expression (Figure 4D). For
example, SPATA5 (a human homolog of yeast Drg1; p =
0.0095), SBDS (p = 0.0003), and LSG1 (p = 0.0084) (Figure 4E),
which are all involved in the final step of 60S maturation and
the atypical RIO kinases RIOK1 (p = 0.0097) and RIOK2 (p =
0.0076; Figure 4F), involved in the final step of 40S maturation
(Vanrobays et al., 2003), all showed significantly increased pro-
tein expression within the low XIST population. Interestingly, all
of these proteins are involved in the cytoplasmic quality control
of ribosomes (Cerezo et al., 2019; Karbstein, 2013; Peña et al.,
2017). To drill down further into the process of ribosome subunit
biogenesis, we performed a more granular enrichment analysis
on the proteins involved within this pathway and found the high-
est enrichment was on terms related to large subunit biogenesis
and ribosomal RNA (Figure 4G)
Proteome-specific changes affecting ribosomes and
translation initiation
When we focused on the total estimated copy numbers for the
cytoplasmic ribosomes, we noticed they mirrored the protein
content closely, with a mean increase of 13% (p = 0.0019) in
the low XIST population (Figure 5A). Interestingly, the changes
were not uniform between the large subunit (60S) and the small
subunit (40S). The largest increase in the low XIST population
affected proteins belonging to the 60S (Figure 5B), resulting in
a significant change (p = 0.0053) in the ratio of protein copy
numbers between 60S and 40S ribosomal proteins (Figure 5C).
Overall, 42% of the ribosomal proteins and ribosomal S6 ki-
nases detected were significantly increased in expression in
the low XIST population (Figure 5D). Of these proteins, the one
with the highest p value (p < 6.86e07) was p90 ribosomal S6 ki-
nase (RPS6KA3), which is encoded on the X chromosome and is
linked to cell growth by increased cap-dependent translation
through phosphorylation of RPS6 (Roux et al., 2007) and RPTOR
(Carrière et al., 2008; for all significantly increased X-linked ki-
nases see Figure S4).
As RPS6KA3 is an X-linked kinase, we checked the ratio of
reads mapped to the secondary allele compared to the primary
allele and detected significant differences between the high
and low XIST lines (p = 0.00011). Thus, the median ratio for the
high XIST population was 0.07, whereas the median ratio in theFigure 4. Ribosome biogenesis
For all boxplots, the bottom and top hinges represent the 1st and 3rd quartiles. Th
IQR from the hinge; the bottom whisker extends from the hinge to the smallest v
(A) Boxplot showing the number of proteinswith copy numbers greater than the 75
simulations and the actual experimental data (see STAR Methods).
(B) Boxplot showing the hypergeometric p value for proteins with copy numbers gr
percentile for the simulations and the actual experimental data (see STAR Metho
(C) Scatterplot showing the log2 fold change (low/high XIST) at the protein and R
proteins are highlighted, and Pearson correlation coefficients are provided.
(D) Schematic showing the cytoplasmic ribosome biogenesis proteins with prote
(E) Boxplot showing the protein copy numbers for SBDS, LSG1, and SPATA5 wi
(F) Boxplot showing the protein copy numbers for RIOK1 and RIOK2 within the l
(G) Treemap plot showing the results of a biological process overrepresentation te
to the enrichment level of the specific terms.low XIST population was 0.44 (Figure 5E). We also detected a
significantly higher expression of RPS6KA3 within the low XIST
compared to the high XIST population, in both the RNA-seq (Fig-
ure 5F) and proteomics (Figure 5G) datasets. These data support
a model in which transcriptional derepression of the inactive X
chromosome in low XIST lines increases the expression of pro-
teins encoded on the X, which in turn can increase mRNA trans-
lation and protein expression for autosomal genes.
We next looked for additional X-linked gene products with the
potential to affect mRNA translation, focusing on the translation
initiation factors EIF2S3 and EIF1AX. These proteins both form
part of the 43S translation preinitiation complex (Jackson et al.,
2010). EIF2S3 is a member of the heterotrimeric eIF2 complex,
which delivers an initiator methionyl transfer RNA to the ribo-
some. Based on the protein expression data in this study,
EIF2S3 appears to be the rate-limiting subunit of the eIF2 com-
plex within the iPSC lines (Figure S5). As seen with RPS6KA3,
a significantly higher ratio of reads from the secondary allele of
EIF2S3 are seen within the low XIST compared to the high
XIST population (p = 9.2e7; Figure 6A), together with signifi-
cantly higher expression at theRNA-seq (p = 2.67e15; Figure 6B)
and proteomics (p = 0.0017; Figure 6C) levels . Similarly, EIF1AX
is involved in virtually all the steps in mRNA translation initiation,
from the pre-initiation to ribosomal subunit joining (Nag et al.,
2016), and it shows a dramatic median increase of over 2.3
million protein copies in the low XIST population. A higher me-
dian fraction of reads was seen from the EIF1AX secondary allele
(0.31 in the low XIST versus 0.13 in the high XIST; Figure 6D).
However, this difference did not meet a statistically significant
threshold, likely due to outlier lines within the high XIST popula-
tion with a high ratio of reads from the secondary allele. Nonethe-
less, the expression levels of EIF1AX at both the RNA-seq
(p = 2.16e6; Figure 6E) and proteomics (p = 9.34e8; Figure 6F)
levels were significantly increased in the low XIST population. To
validate further the MS-based identifications and quantifica-
tions, we mapped the peptide coverage for all 3 X-linked trans-
lational modulators (i.e., RPS6KA3, EIF2S3, and EIF1AX), which
revealed robust results with high numbers of RUPs (all over 10
RUP) detected, as well as high sequence coverage (all over
53%; Figure S6).
The potential impact of eroded XCI on factors affecting the ef-
ficiency of translation initiation was not limited to an upregulation
of proteins encoded by genes on the X chromosome only. For
example, eIF4F is another complex that is vital for translatione top whisker extends from the hinge to the largest value no further than 1.5 3
alue at most 1.5 3 IQR of the hinge.
th percentile andRazor + unique peptides greater than the 75th percentile for the
eater than the 75th percentile and Razor + unique peptides greater than the 75th
ds).
NA level. Ribosome biogenesis and cytoplasmic and mitochondrial ribosomal
ins significantly increased in expression highlighted in orange.
thin the low and high XIST populations.
ow and high XIST populations.
st focused on ribosome biogenesis proteins. The rectangle size is proportional
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Figure 5. Ribosomes and translational initia-
tion
For all boxplots, the bottom and top hinges repre-
sent the 1st and 3rd quartiles. The top whisker ex-
tends from the hinge to the largest value no further
than 1.5 3 IQR from the hinge; the bottom whisker
extends from the hinge to the smallest value at most
1.5 3 IQR of the hinge.
(A) Boxplot showing the copy numbers for the sum
of all cytoplasmic ribosomal proteins within the high
and low XIST populations.
(B) Boxplot showing the copy numbers for the sum
of all 60S (large ribosomal subunit) and 40S (small
ribosomal subunit) proteins within the high and low
XIST populations.
(C) Boxplot showing the ratio of the sum of 60S to
40S ribosomal proteins within the high and low XIST
populations.
(D) Volcano plot showing the protein log2 fold
change (low/high XIST) on the x axis, with thelog10
p value on the y axis. Ribosomal proteins and ri-
bosomal S6 kinases are highlighted in pink; all other
proteins are colored gray. All proteins above the
orange line have a p value lower than 0.05.
(E) Boxplot showing the ratio of reads mapped to
the secondary allele compared to the primary allele
for RPS6KA3 within the High, Medium and Low
XIST populations.
(F) Boxplot showing the log2 TPM of RPS6KA3
within the high, medium, and low XIST populations.
(G) Boxplot showing the protein copy numbers of
RPS6KA3 within the high, medium, and low XIST
populations.




Figure 6. Translational machinery
For all boxplots, the bottom and top hinges represent the 1st and 3rd quartiles. The top whisker extends from the hinge to the largest value no further than 1.5 3
IQR from the hinge; the bottom whisker extends from the hinge to the smallest value at most 1.5 3 IQR of the hinge.
(A) Boxplot showing the ratio of readsmapped to the secondary allele (lowest expressed allele) compared to the primary allele (highest expressed allele) of EIF2S3
within the high, medium, and low XIST populations.
(B) Boxplot showing the log2 TPM for EIF2S3 within the high, medium, and low XIST populations.
(C) Boxplot showing the protein copy numbers for EIF2S3 within the high, medium, and low XIST populations.
(D) Boxplot showing the ratio of reads mapped to the secondary allele compared to the primary allele for EIF1AX within the high, medium, and low XIST pop-
ulations.
(E) Boxplot showing the log2 TPM of EIF1AX within the high, medium, and low XIST populations. The bottom and top hinges represent the 1
st and 3rd quartiles.
(F) Boxplot showing the protein copy numbers of EIF1AX within the high, medium, and low XIST populations.
(G) Schematic showing the protein copy numbers for the eIF4F complex and its inhibitors displayed for both the high and low XIST populations. Proteins rep-
resented by red boxes are significantly increased, light blue boxes are significantly decreased, and elements in gray boxes remain unchanged.
(H) Ribo-Mega-SEC-derived line plot showing the mean high and low XIST polysome profile, with the colored ribbon representing the standard deviation.
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OPEN ACCESSinitiation (Merrick, 2015). It is composed of the alpha (EIF4A1 and
EIF4A3), epsilon (EIF4E), and gamma (EIF4G1 and EIF4G3) sub-
units. The stoichiometry of EIF4E, the cap-binding subunit
(located on chromosome 4), to its inhibitors EIF4EBP1 (located
on chromosome 8) and EIF4EBP2 (located on chromosome 10)
has been proposed as one of the regulatory mechanisms for
eIF4F translational control (Richter and Sonenberg, 2005).Interestingly, in the low XIST population, there is a significant in-
crease (p = 0.0006) in EIF4E levels compared to the high XIST
population, alongside a parallel significant decrease (p = 0.007)
in the levels of EIF4EBP1 (Figure 6G). The decrease in EIF4EBP1
is particularly relevant in this case, as only 1.2% of all proteins
are significantly decreased in expression in the low XIST
population.Cell Reports 35, 109032, April 27, 2021 11
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low XIST population, causing a major change in the proteome
that results in a global increase in total protein levels, which is
mediated, at least in part, by increased levels of translation. To
test the hypothesis that the low XIST population has increased
translational capacity, we compared polysome and ribosome
profiles between iPSC lines showing either high or low levels of
XIST RNA by using the Ribo Mega-size exclusion chromatog-
raphy (SEC) method (Yoshikawa et al., 2018). This SEC-based
method can separate large protein complexes, including poly-
somes, 80S monosomes, and ribosome subunits.
The Ribo Mega-SEC data were remarkably consistent with the
MS-based proteomics data. This result showed that both the
polysome-containing fractions and 80S-monosome-containing
fractions are increased significantly in extracts from iPSC lines
with low levels of XIST RNA compared to extracts from iPSC lines
with high levels of XIST RNA (Figure 6H). Moreover, the SEC data
show amore pronounced increase within the low XIST population
in the ratio of the 60S to the 40S ribosome subunits, consistent
with a larger increase in 60S ribosomal protein levels in the MS
data (Figures 5B and 5C). The polysome fractionation data are
thus consistent with a model in which erosion of XCI in the iPSC
lines expressing low levels of XIST RNA upregulates the protein
translation capacity and leads to a global increase in protein levels
from multiple genes on both autosomes and the X chromosome.
DISCUSSION
This study provides an in-depth global analysis of how erosion of
X chromosome inactivation (XCI) affects gene expression and
dosage compensation at the protein level in human cells and
compares this analysis to matching RNA-seq data. We analyzed
RNA expression in 74 independent human iPSC lines derived
from healthy female donors that were generated by the HipSci
consortium (Kilpinen et al., 2017). This analysis showed that
40% of these lines expressed very low levels of XIST, a long
non-coding RNA vital for the establishment of XCI (Marahrens
et al., 1997; Penny et al., 1996). Further analysis of allelic expres-
sion fromX-chromosome-encoded genes showed that low levels
of XIST RNA strongly correlated with erosion of XCI, as reflected
by a significantly increased fraction of reads beingmapped to the
lowest expressed (secondary) allele (higher biallelic expression).
We therefore characterized how the erosion of XCI remodels
gene expression and the human proteome by comparing in detail
the levels of RNA and protein expression across 56 female iPSC
lines, stratified according to high versus low XIST RNA levels, as
well as comparing them to 46 lines derived from healthymale do-
nors, which have only 1 X chromosome.
First, the data show that the low XIST population significantly
upregulated the expression of many gene products on the X
chromosome at both RNA and protein levels. Considering the
evidence of increased biallelic expression within that same pop-
ulation, these data indicate that erosion of XCI causes increased
protein expression from X-linked genes, primarily by a transcrip-
tional mechanism.
We also leveraged the distinct characteristics of our dataset to
compare how protein expression levels are affected by dosage
compensation in the respective high and low XIST-stratified fe-12 Cell Reports 35, 109032, April 27, 2021male lines versus the male lines. The data indicate that
compared to the males, the high XIST lines, which exhibit robust
XCI, show similar patterns of expression for genes derived from
the X chromosome. This result suggests that when XIST levels
are high, there is effective dosage compensation for the extra
X chromosome copy, acting at the protein level. However, for
the lines with low XIST expression levels, which exhibit higher
erosion of XCI, a very different situation is evident. In this case,
the total copies of X-chromosome-encoded proteins are
increased in expression by 27% compared to males, which
makes the gene expression from the X chromosome significantly
different between males and females.
Second, we also detected a significant increase in protein
expression levels from 26% of autosomal genes within the low
XIST female lines. In contrast to genes on the X chromosome,
21% of all autosomal gene products were increased only at
the protein level and not the RNA level. Thus, autosome-en-
coded genes showed a low overall RNA:protein fold change cor-
relation (median Pearson correlation for autosomes of 0.27,
compared with 0.56 for the X chromosome).
It should be noted that, unlike the RNA-seq data, protein copy
numberscanbeestimated fromtheMSdataby theproteomic ruler
without the need for spike-ins (Wisniewski et al., 2014). The esti-
mated copynumbers allowus tocalculate and explore differences
in absolute protein content. With this RNA-seq dataset and
normalization approach, which did not include spike-in controls,
it is not possible to detect potential transcriptional amplificationef-
fects (Lovén et al., 2012). Furthermore, recent reports have sug-
gested that in mESCs, changes in ERK signaling can cause hypo-
methylation (Choi et al., 2017; Song et al., 2019), potentially also
affectingglobal transcription.Ourdata reveal thatmultipleX-linked
kinases associated with ERK signaling are significantly increased
in expression within the low XIST population (Figure S4). Their
contribution to cell phenotypes here remains to be determined.
Therefore,wecannot completely exclude thepossibility that abso-
lute changes at the transcript level may also occur for autosomal
genes, which would be masked due to technical issues in the
detection of transcriptional amplification. Moreover, although
erosion of XCI is generally thought to specifically affect the expres-
sion of X-linked genes, we note that increased transcription from
autosomal genes has been reported in murine trophoblasts
when they failed to induce XCI (Sakata et al., 2017). Nonetheless,
the data from our study indicate that erosion of XCI in human cells
can affect protein levels encoded by amuchwider range of genes
than was previously shown by RNA-seq data alone, including
autosome-linked genes and disease loci.
Third, the comparison of high versus low XIST iPSC popula-
tions showed that the low-XIST-expressing cell lines had a me-
dian increase of 13% in total protein content, which was also
significantly higher than the protein content of the lines derived
from healthy male donors. Considering potential mechanisms
that could cause this increased protein content, we found
several lines of evidence that suggest it may result, at least
in part, from post-transcriptional regulation affecting the transla-
tion efficiency of a subset of mRNAs. It has been proposed that
translation rates positively correlate with protein abundance
(Brockmann et al., 2007; Liu et al., 2016; Marguerat et al.,
2012). Congruently, our data show the autosome-encoded
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OPEN ACCESSproteins that are significantly increased in expression, but
without a corresponding mRNA increase, are enriched in high
abundance proteins with high peptide counts.
Focusing on the proteins that show statistically significant,
RNA-independent increases in expression in low XIST popula-
tion revealed an enrichment for GO terms associated with ribo-
nucleoprotein complex biogenesis. Furthermore, by conducting
independent polysome profiling analyses comparing high and
low XIST iPSC lines, using the Ribo Mega-SEC method (Yoshi-
kawa et al., 2018), we also showed a significant increase in the
polysomes and 80S ribosomes within the low XIST lines. Thus,
analyses using both the separate MS proteomics and polysome
methods, support the view that iPSCs derived from healthy fe-
male donors showing XCI erosion have increased protein trans-
lation activity, resulting in a global increase in total protein levels.
It will be interesting to analyze in the future whether mRNAs en-
coding the subset of autosomal proteins that show increased
abundance share some common features or sequence motifs
that promote efficient translation.
In light of the elevated protein content and polysome levels
observed in the low XIST iPSC population, it is interesting that
two X-linked genes that encode important regulators of transla-
tional initiation (EIF1AX and EIF2S3), as well as a kinase known to
modulate translation (RPS6KA3), all show highly increased
expression at both the RNA and protein levels. It has been pro-
posed that protein synthesis is principally regulated at the initia-
tion stage (Jackson et al., 2010). Therefore EIF1AX and EIF2S3
are thus candidates for mediating, at least in part, the mecha-
nismwhereby erosion of XCI causes an increase in protein trans-
lational capacity. Interestingly, both the EIF1AX and EIF2S3
genes have previously been categorized as facultative XCI es-
capees (Belling et al., 2017; Zhang et al., 2013), meaning they
are among a subset of X-linked genes that can escape transcrip-
tional repression, despite the globally repressed state. This local
increased gene dosage effect suggests that even female lines
with normal XCI may differ in translational capacity from male
cells with only a single X chromosome.
Our data show that erosion of XCI in human cells has the po-
tential to cause major changes at the level of protein expression,
which in turn could have important implications for disease pro-
gression and response to therapy in females. The potential clin-
ical relevance is amplified by our finding that the expression of
numerous autosomal genes also respond to erosion of XCI at
the protein level. Many of these significantly increased proteins
encoded on autosomes, such as ERK2, FYN, and CDK6, are
linked to cancer and other diseases (Papa et al., 2019; Saito et
al., 2010; Yang et al., 2017). It will also be of interest to analyze
whether, or to what extent, the loss of XIST expression can
display similar consequences in vivo, as it has been reported
that multiple cell types and tissues have reduced or no XIST
expression (Syrett et al., 2017; Wang et al., 2016).STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All lines included in this study are part of the HipSci resource and were reprogrammed from primary fibroblasts as previously
described (Kilpinen et al., 2017). Out of the total of more than 800 iPSC lines available within the HipSci resource (https://www.
hipsci.org), 120 derived from healthy donors andwith proteomic analysis were used in this study. All lines derived from healthy female
donors (subset of 74 iPSC lines) were then used for the XCI analysis and included all lines derived from healthymale donors (subset of
46 iPSC lines) for the dosage compensation analysis.
METHOD DETAILS
TMT Sample preparation
The data presented here is a subset of the total HipSci proteomics dataset (Brenes et al., 2019; Mirauta et al., 2020). For protein
extraction, iPSC cell pellets were washed with ice cold PBS and redissolved immediately in 200 mL of lysis buffer (8 M urea in
100 mM triethyl ammonium bicarbonate (TEAB)) and mixed at room temperature for 15 minutes. The DNA content of the cells
was sheared using ultrasonication (6 X 20 s on ice). The proteins were reduced using tris-carboxyethylphosphine TCEP (25 mM)
for 30 minutes at room temperature, then alkylated in the dark for 30 minutes using iodoacetamide (50 mM). Total protein was quan-
tified using the EZQ assay (Life Technologies). The lysates were diluted with 100 mM TEAB 4-fold for the first digestion with mass
spectrometry grade lysyl endopeptidase, Lys-C (Wako, Japan), then further diluted 2.5-fold before a second digestion with trypsin.e1 Cell Reports 35, 109032, April 27, 2021
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stopped by acidification with trifluoroacetic acid (TFA) to a final concentration of 1% (v:v). Peptides were desalted using C18 Sep-Pak
cartridges (Waters) following manufacturer’s instructions.
For tandemmass tag (TMT)-based quantification, the dried peptides were re-dissolved in 100 mM TEAB (50 ml) and their concen-
tration wasmeasured using a fluorescent assay (CBQCA, Life Technologies). 100 mg of peptides from each cell line to be compared,
in 100 mL of TEAB, were labeled with a different TMT tag (20 mg ml1 in 40 mL acetonitrile) (Thermo Scientific), for 2 h at room tem-
perature. After incubation, the labeling reaction was quenched using 8 mL of 5% hydroxylamine (Pierce) for 30 min and the different
cell lines/tags were mixed and dried in vacuo.
The TMT samples were fractionated using offline high-pH reverse-phase (RP) chromatography: samples were loaded onto a 4.63
250 mm Xbridge BEH130 C18 column with 3.5-mm particles (Waters). Using a Dionex bioRS system, the samples were separated
using a 25-min multistep gradient of solvents A (10 mM formate at pH 9) and B (10 mM ammonium formate pH 9 in 80% acetonitrile),
at a flow rate of 1mLmin1. Peptides were separated into 48 fractions, whichwere consolidated into 24 fractions. The fractions were
subsequently dried and the peptides re-dissolved in 5% formic acid and analyzed by LC–MS/MS.
TMT LC–MS/MS
The data presented here is a subset of the total HipSci proteomics dataset (Brenes et al., 2019; Mirauta et al., 2020). Samples were
analyzed using an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific), equipped with a Dionex ultra-high-pressure liquid-
chromatography system (RSLCnano). RPLC was performed using a Dionex RSLCnano HPLC (Thermo Scientific). Peptides were
injected onto a 75 mm 3 2 cm PepMap-C18 pre-column and resolved on a 75 mm 3 50 cm RP- C18 EASY-Spray temperature-
controlled integrated column-emitter (Thermo Scientific), using a four-hour multistep gradient from 5% B to 35% B with a constant
flow of 200 nL min1. The mobile phases were: 2% ACN incorporating 0.1% FA (solvent A) and 80% ACN incorporating 0.1% FA
(solvent B). The spray was initiated by applying 2.5 kV to the EASY-Spray emitter and the data were acquired under the control of
Xcalibur software in a data-dependentmode using top speed and 4 s duration per cycle. The survey scanwas acquired in the orbitrap
covering the m/z range from 400 to 1,400 Thomson with a mass resolution of 120,000 and an automatic gain control (AGC) target of
2.03 105 ions. The most intense ions were selected for fragmentation using CID in the ion trap with 30%CID collision energy and an
isolation window of 1.6 Th. The AGC target was set to 1.03 104 with a maximum injection time of 70 ms and a dynamic exclusion of
80 s.
During the MS3 analysis for more accurate TMT quantifications, 5 fragment ions were co-isolated using synchronous precursor
selection using a window of 2 Th and further fragmented using HCD collision energy of 55%. The fragments were then analyzed
in the orbitrap with a resolution of 60,000. The AGC target was set to 1.0 3 105 and the maximum injection time was set to 105 ms.
Ribo Mega-SEC iPSC lines cell culture
For the Ribo Mega-SEC analyses 4 iPSC lines with High XIST RNA levels (‘iiyk_20, ‘iiyk_4’, ‘nufh_30 and nufh_4’) and 3 lines with Low
XIST RNA levels (‘fawm_4’, ‘bawa_1’ and ‘aizi_30) were used. The lines were maintained in TESR medium (Ludwig et al., 2006), sup-
plemented with FGF2 (Peprotech, 30 ng/ml) and noggin (Peprotech, 10 ng/ml), on growth factor reduced geltrex basement mem-
brane extract (Life Technologies, 10 mg/cm2) coated dishes at 37C in a humidified atmosphere of 5% CO2 in air.
Cells were routinely passaged twice a week as single cells, using TrypLE select (Life Technologies) and replated in TESR medium
that was further supplemented with the Rho kinase inhibitor Y27632 (Tocris, 10 mM), to enhance single cell survival. Twenty-four
hours after replating, Y27632 was removed from the culture medium. For proteomic analyses, cells were plated in 100 mm geltrex
coated dishes at a density of 5x104 cells cm-2 and allowed to grow to for 3 days, until confluent, with daily medium changes.
Ribo Mega-SEC
Ribo Mega-SEC for the separation of polysomes and ribosomal subunits using size exclusion chromatography was performed as
previously reported (Yoshikawa et al., 2018), with a slight modification. Briefly, 2.5 3 106 cells were washed once with ice-cold
PBS, scraped in ice-cold PBS and collected by centrifugation at 500 g for 5 min (all centrifugations at 4C). The cells were lysed
by vortexing for 10 s in 250 mL of polysome extraction buffer (20 mM HEPES-NaOH (pH 7.4), 130 mM NaCl, 10 mMMgCl2, 5% glyc-
erol, 1%CHAPS, 0.2 mg/ml heparin, 2.5 mMDTT, 20 U SUPERase In RNase inhibitor, cOmplete EDTA-free Protease inhibitor), incu-
bated for 15 min on ice, and centrifuged at 17,000 g for 10 min. Supernatants were filtered through 0.45 mm Ultrafree-MC HV
centrifugal filter units (Millipore).
Using a Dionex Ultimate 3,000 Bio-RS uHPLC system (Thermo Fisher Scientific), a SEC column (Agilent Bio SEC-5, 2,000 Å pore
size, 7.83 300 mmwith 5 mmparticles) was equilibrated with three column volumes of filtered SEC buffer (20 mMHEPES-NaOH (pH
7.4), 60mMNaCl, 10mMMgCl2, 0.3%CHAPS, 0.2mg/ml heparin, 2.5mMDTT, 5%glycerol) (all column conditioning and separation
at 5C) and 100 mL of 10mg/ml of filtered bovine serum albumin (BSA) solution diluted by PBSwas injected once to block the sites for
non-specific interactions. After monitoring the column condition by injecting standards, including 10 mL of 10 mg/mL BSA solution
and 5 mL of HyperLadder 1 kb (BIOLINE), 200 mL of the filtered cell lysates was injected onto the pre-equilibrated SEC column. The
flow rate was 0.4 mL/min and the chromatogram was monitored by measuring UV absorbance at 215, 260 and 280 nm with a 1 Hz
data collection rate by the Diode Array Detector.Cell Reports 35, 109032, April 27, 2021 e2
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Raw RNA-seq data were obtained from the ENA project: PRJEB7388. CRAM files were merged on a sample level and converted to a
single FASTQ file per sample. Sequencing reads were trimmed to remove adapters and low-quality bases (Trim Galore!), followed by
read alignment using STAR (v.020201) (Dobin et al., 2013), using the two-pass alignment mode and the default parameters as pro-
posed by ENCODE (c.f. STAR manual). All alignments were relative to the GRCh37 reference genome, using ENSEMBL 75 as tran-
script annotation (Zerbino et al., 2018).
Samples with low quality RNA-seq were discarded if they had either less than 2 billion bases aligned, had less than 30% coding
bases, or had a duplication rate higher than 75%. Gene-level RNA expression was quantified from the STAR alignments using fea-
tureCounts (Liao et al., 2014) (v1.6.0), which was applied to the primary alignments using the ‘‘-B’’ and ‘‘-C’’ options in stranded
mode, using the ENSEMBL 75 GTF file. Quantifications per sample were merged into an expression table using the following normal-
ization steps. First, gene counts were normalized by gene length. Second, the counts for each sample were normalized by
sequencing depth using the edgeR (Robinson et al., 2010) adjustment. Transcript isoform expression was quantified directly from
the (unaligned) trimmed reads using Salmon (Patro et al., 2017) (v0.8.2), using the ‘–seqBias’, ‘–gcBias’ and ‘VBOpt’ options in
‘ISR’mode tomatch our inward stranded sequencing reads. The transcript databasewas built on transcripts derived from ENSEMBL
75. The TPM values as returned by Salmon were combined into an expression table.
Allele specific analysis
Allele-specific quantification of expression from the X chromosome was calculates using RNA-Seq reads mapping to the X chromo-
some. Allele-specific counts were obtained from SNPs present in DBSNP using GATK ReadCounter with the command ‘GenomeA-
nalysisTk.jar -T ASEReadCounter -U ALLOW_N_CIGAR_READS –minMappingQuality 10 –minBaseQuality 20, restricted to SNPs
which were known to be heterozygous in the analyzed sample. The allele-specific fraction of expression was defined as the fraction
of transcript readsmapping to the less expressed allele, restricting to heterozygous X chromosomeSNPswith at least 20 overlapping
reads. These fractions were then averaged across SNPs at a whole-chromosome level (Figures 2A and 2C), and for individual genes
(Figures 6A and 6D). Note that, for a given gene in a given sample, this quantification could only be performed when the donor for that
sample carries a heterozygous common variant in that gene. This reduced the number of samples for which allele-specific expression
could be computed for each gene.
Primary versus secondary allele
The primary allele for each iPSC line is defined as the allele with the highest number of transcript reads mapping to it. Conversely the
secondary allele is defined as the allele with the lowest number of transcript reads mapped to it.
Proteomics data processing
The TMT-labeled samples were collected and analyzed using Maxquant (Cox and Mann, 2008; Tyanova et al., 2016) v. 1.6.3.3. The
FDR threshold was set to 1% for each of the respective Peptide Spectrum Match (PSM) and Protein levels. The data were searched
with the following parameters; type was set to Reporter ion MS3 with 10plex TMT, stable modification of carbamidomethyl (C), var-
iable modifications, oxidation (M), acetylation (protein N terminus), deamidation (NQ), Glutamine to pyro-glutamate (N terminus), with
a 2 missed tryptic cleavages threshold, reporter mass tolerance set to 0.03 ppm. Minimum peptide length was set to 7 amino acids.
Proteins and peptides were identified using UniProt (SwissProt December 2018). Run parameters have been deposited to PRIDE
(Perez-Riverol et al., 2019) along with the full MaxQuant quantification output (PDX010557).
Razor + unique peptides
Peptides that are unique to a single protein sequence are known as ‘‘unique peptides’’ and peptides that are shared betweenmultiple
protein sequences are known as ‘‘shared peptides.’’ Within MaxQuant, shared peptides are assigned to a single protein group,
following Occam’s Razor. The number of unique peptides, plus the number of shared peptides used for the quantification of a protein
group, is referred to as Razor + unique peptides.
iPSC Copy number generation
Protein copy numbers were calculated using the proteomic ruler (Wisniewski et al., 2014) and using the MS3 reporter intensity. An
additional batch correction factor for each TMT experiment was applied as previously described (Brenes et al., 2019).
Protein content
The protein content for all iPSC lines was calculated based on the copy numbers. The molecular weight of each protein (converted to
picograms) was multiplied by the number of copies for the corresponding protein and this was then summed for all proteins across




To map gene products to their specific chromosomes, we utilized the UniProt (The UniProt Consortium, 2017) protein-chromosome
mapping service.We used their output to produce a list of unique proteins for each specific chromosome. Subsequently, wemapped
the proteins detected in our iPSC dataset to their corresponding chromosomes, based on the UniProt mapping file.
X-inactivation stratification and analysis
Based on the RNaseq data, 74 iPSC lines were classified into 3 distinct categories, based on XIST expression. 30 iPSC lines where
XIST expression was < 1 Log2 TPM were classified as ‘Low XIST’. 35 iPSC lines where XIST expression was higher than 2.75 Log2
TPM were classified as High XIST and the remaining 9 lines were classified as ‘Medium’ XIST.
High XIST filtering
The High XIST population contained two proteomic experiments, PT7422 and PT6386, contributing a large number of High XIST rep-
licates within their 10-plex TMT experiment. As the maximum number of replicates per 10-plex within the Low XIST group was 4, we
performed hierarchical clustering to reduce the number of lines contributed by PT7422 and PT6386 to a maximum of 4, in order to
minimize batch effects. The final number of lines with High XIST, post filtering, was 26.
GO Enrichment analysis
All of the GO enrichment analyses were done using Panther (Mi et al., 2017) and used the 8,511 proteins that were detected in both
the RNaseq and proteomics datasets as background. We performed a biological process overrepresentation analysis for all proteins
that were significantly increased (q-value < 0.05), where the corresponding transcript was not significantly increased in expression.
Furthermore, an additional biological process overrepresentation of significantly increased (q-value < 0.05) ribosome biogenesis pro-
teins was carried out.
Hypergeometric analysis
The hypergeometric analyses were all done in R using the phyper function from the stats package (v.3.6.0). For this analysis, a subset
of proteins (1,825), which were significantly increased in expression without a correspondingmRNA increase, were selected. We first
looked at the number of proteins within the previous subset with a peptide count either greater than, or equal to, the 75th percentile (26
peptides) and used phypher to determine hypergeometric p values. We then compared this result to the one produced by randomly
selecting 1,825 proteins and repeating the previous process. This was done 100,000 times. We also looked at the number of proteins
with copy numbers either greater than, or equal to, the 75th percentile (407,724 copies) and used phypher to determine hypergeo-
metric p values. We then compared this result to the one produced by randomly selecting 1,825 proteins and repeating the previous
process. This was done 100,000 times.
60S/40S ratio
The ratios were calculated by summing the copy numbers from all proteins of the 60S ribosomal subunit, divided by the sum of all
copy numbers from the 40S ribosomal subunit, for each individual iPSC line.
UniProt to Ensembl mapping
Mapping of UniProt accessions to Ensembl gene identifiers was done in R using the ‘‘UniProt.ws’’ package version 2.24.1
Kinase map
The kinase map was generated within the Encyclopedia of Proteome Dynamics (Brenes et al., 2018) using the KinoViewer (Brenes
and Lamond, 2019).
Sequence coverage maps
The sequence coverage maps for EIF1AX, EIF2S3 and RPS6KA3 were generated using Jalview (Waterhouse et al., 2009) version
2.11.1.3
QUANTIFICATION AND STATISTICAL ANALYSIS
The proteomics data used for the analysis were obtained from the ProteinGroups.txt output of Maxquant (Cox andMann, 2008; Tya-
nova et al., 2016) v. 1.6.3.3. Contaminants, reverse hits and ‘only identified by site’ proteins were excluded from analysis. Overall, we
quantified 9,631 protein groups in at least one of the samples. For additional stringency and to reduce batch variation, only proteins
with 3 or more ‘Razor + unique peptides’ were considered.
Fold changes and P values were calculated in R utilizing the bioconductor package LIMMA (Ritchie et al., 2015) version 3.7. FDR
calculations were performed in R with the ‘‘qvalue’’ package version 2.10.0. For both the RNaseq and proteomics differential expres-
sion analyses, gene products with a Q-value % 0.05 were considered significant. For comparisons looking at individual gene prod-
ucts or aggregated gene families, Welch’s t test was used. In this case results with a p value % 0.05 were considered significant.Cell Reports 35, 109032, April 27, 2021 e4
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Figure S1 – XACT and XCI: (a) Scatter plot showing the fraction of reads derived from the secondary (lowest 
expressed) allele compared to the primary (highest expressed) allele for all X-linked transcripts vs the log2 XACT 
TPM for all healthy female lines. The size is determined by the number of transcripts used for the analysis. Related 




Figure S2 – Cell cycle markers: All box plots show the log2 TPM and estimated protein copy numbers within 
the High, Medium and Low XIST populations for a gene product. The upper whisker extends from the hinge to 
the largest value no further than 1.5 * IQR from the hinge, the lower whisker extends from the hinge to the smallest 
value at most 1.5 * IQR of the hinge. (a) Boxplots for AURKA. (b) Boxplots for AURKB. (c) Boxplots for BUB1. 
(d) Boxplots for BUB1B. (e) Boxplots for CCNA2. (f) Boxplots for CCNB1. (g) Boxplots for CCNB2. (h) 
Boxplots for CCND1. (i) Boxplots for CCND2. (j) Boxplots for CDT1. (k) Boxplots for ORC1. (l) Boxplots for 






Figure S3 – High, Medium and Low XIST protein level data : For all box plots the upper whisker extends 
from the hinge to the largest value no further than 1.5 * IQR from the hinge, the lower whisker extends from the 
hinge to the smallest value at most 1.5 * IQR of the hinge. (a) Box plot showing the estimated protein content 
(see methods) for the High, Medium and Low XIST. (b) Boxplot showing the sum of protein copy numbers across 
the X chromosome for the High XIST, Medium and Low XIST lines. (c) Boxplot showing the sum of protein 
copy numbers across all autosomes for the High XIST, Medium and Low XIST lines. (d) Boxplot showing the 
median protein log2 fold change for the High, Medium and Low XIST populations when compared to the male 
lines across all chromosomes. Related to Figure 3. 
 
Figure S4 – X-linked Kinome: Protein level kinase map for all kinases showing the log2 fold change (Low/High 





Figure S5 – eIF2 copy numbers: Box plot for the High and Low XIST populations showing the estimated copy 
numbers for EIF2S1, EIF2S2 and EIF2S3. The lower and upper hinges represent the 1st and 3rd quartiles. The 
upper whisker extends from the hinge to the largest value no further than 1.5 * IQR from the hinge, the lower 






Figure S6 – Peptides and sequence coverage: (a) Map showing the amino acid sequence and MS derived peptide 
coverage for RPS6KA3. (b) Map showing the amino acid sequence and MS derived peptide coverage for EIF2S3. 
(c) Map showing the amino acid sequence and MS derived peptide coverage for EIF1AX. Related to Figures 5 & 
6. 
 
